Bicycle Therapeutics (BCYC)Officer sold ~$1.8K

~$1.8K

Approx. value · 248 sh @ $7.44

54K

Holds after · shares reported

Traded

Jul 3, 2025

Filed

Jul 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 2, 2025Insider · 6 peopleInsiders: 6 sales (~$36K)
2. Jul 3, 2025 · this disclosureInsiderOfficer sold ~$1.8K of BCYC shares in the open market

What came next

1. Jul 3, 2025Insider · 4 peopleInsiders: 4 sales (~$39K)
2. Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective as of September 8, 2025, the Board of Directors (the “Board”) of Bicycle Therapeutics plc (the “Company”) increased the size of the Board from eight to ten directors and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed (i) Roger Dansey, M.D., to the Board as a Class III director, for a term expiring at the Company’s 2028 annual general meeting, and (ii)…”
3. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bicycle Therapeutics

For Bicycle Therapeutics, OQRO holds 12 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BCYC page.

Other recent filings by Michael Charles Ferguson Hannay, CHIEF PROD & SUPPLY CHAIN OFF

• SEC Form 4 at Bicycle Therapeutics (BCYC)Oct 7, 2026
• SEC Form 4 at Bicycle Therapeutics (BCYC)Oct 7, 2026
• SEC Form 4 at Bicycle Therapeutics (BCYC)Jul 7, 2025
• SEC Form 4 at Bicycle Therapeutics (BCYC)Apr 4, 2025
• SEC Form 4 at Bicycle Therapeutics (BCYC)Apr 4, 2025

The full history of Michael Charles Ferguson Hannay, CHIEF PROD & SUPPLY CHAIN OFF is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Bicycle Therapeutics

• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026

Everything OQRO holds on this company is on its BCYC page.